Lake-Bakaar D M, Lindvall S
Scand J Haematol Suppl. 1977;32:107-15. doi: 10.1111/j.1600-0609.1977.tb01223.x.
An iron carbohydrate complex, iron-poly(sorbitol-gluconic acid), Ferastral, was labelled with 59Fe, and its distribution in rats was studied. The animals were intramuscularly treated with a dose of 10 mg of iron/kg. Three groups of animals were used: group A: non-anaemic and group B: anaemic rats, both kept on iron-deficient diet, and group C: non-anaemic rats kept on iron-supplemented diet. Urinary and faecal excretion, distribution in the body and incorporation in blood of the 59Fe was followed up to 28 days. The total excretion after that time was 15%. There was a rapid initial phase followed by a slower continuous one. After 28 days group A had 25, group B 13 and group C 40% of the given dose remaining at the site of injection. The corresponding values in liver after 28 days were 7, 4 and 17% of the given dose, respectively. In blood a continuous increase was observed. At 28 days after administration 26, 43 and 17% of the given dose had been incorporated in the red blood corpuscles of the respective groups. These results show that the iron complex is absorbed from the site of injection and is utilized for haemoglobin synthesis. They also show that the disposition of the complex is influenced by the iron content of the diet.
一种铁碳水化合物复合物,铁-聚(山梨醇-葡萄糖酸),即费拉斯特,用59Fe进行标记,并研究了其在大鼠体内的分布情况。给动物肌肉注射剂量为10毫克铁/千克。使用了三组动物:A组:非贫血大鼠;B组:贫血大鼠,两组均采用缺铁饮食;C组:采用补铁饮食的非贫血大鼠。对59Fe的尿排泄、粪排泄、体内分布及在血液中的掺入情况进行了长达28天的跟踪研究。该时间段后的总排泄率为15%。起初有一个快速阶段,随后是一个较慢的持续阶段。28天后,A组有25%、B组有13%、C组有40%的给药剂量残留在注射部位。28天后肝脏中的相应值分别为给药剂量的7%、4%和17%。在血液中观察到持续增加。给药后28天,相应组的红细胞中分别有26%、43%和17%的给药剂量被掺入。这些结果表明,铁复合物从注射部位被吸收并用于血红蛋白合成。它们还表明,复合物的处置受饮食中铁含量的影响。